T-Reg
Showing 1 - 25 of 8,883
Prostate Cancer Trial in Charleston (Simvastatin 40mg)
Recruiting
- Prostate Cancer
- Simvastatin 40mg
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Nov 30, 2022
Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived
Not yet recruiting
- Islet Transplantation
- Infusion of recipient T regulatory cell
- Infusion of concomitant Donor Derived Vertebral Bone Marrow
-
Palo Alto, CaliforniaStanford University
Jul 25, 2023
Kidney Transplant Rejection, End Stage Renal Disease Trial in Belgium, Netherlands, United Kingdom (TX200-TR101)
Recruiting
- Kidney Transplant Rejection
- End Stage Renal Disease
- TX200-TR101
-
Leuven, Belgium
- +4 more
Sep 30, 2022
Type1diabetes Trial in Stockholm, Uppsala (Autologous T regulatory cells)
Active, not recruiting
- Type1diabetes
- Autologous T regulatory cells
-
Stockholm, Sweden
- +1 more
Mar 25, 2021
Chronic GVHD Trial in Bologna (T reg DLI)
Recruiting
- Chronic Graft Versus Host Disease
- T reg DLI
-
Bologna, BO, ItalyUniversity Hospital St. Orsola-Malpighi Polyclinic
Jan 14, 2021
Metastatic Melanoma Trial in Louisville (Ipilimumab)
Terminated
- Metastatic Melanoma
-
Louisville, KentuckyJames Graham Brown Cancer Center
Oct 22, 2021
Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil NS)
Active, not recruiting
- Paroxysmal Supraventricular Tachycardia
- Etripamil NS
-
Gilbert, Arizona
- +123 more
Nov 21, 2022
Hematological Malignancies, Regulatory T Cell Depletion, Relapse Trial in Creteil (T-reg depleted DLI, Standard DLI)
Recruiting
- Hematological Malignancies
- +2 more
- T-reg depleted DLI
- Standard DLI
-
Creteil, FranceHenri Mondor Hospital
Nov 19, 2020
Chronic Spontaneous Urticaria Trial in Worldwide (rilzabrutinib, )
Recruiting
- Chronic Spontaneous Urticaria
- rilzabrutinib
- placebo
-
Caba, Buenos Aires, Argentina
- +66 more
Jan 20, 2023
Plasma Cell Myeloma Recurrent Trial in Australia, Chile (Isatuximab IV, Isatuximab SC, Dexamethasone)
Recruiting
- Plasma Cell Myeloma Recurrent
- Isatuximab IV
- +3 more
-
Salt Lake City, Utah
- +33 more
Jan 16, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Pembrolizumab (Keytruda®), SAR444245 (Thor-707), Cetuximab
Active, not recruiting
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab (Keytruda®)
- +2 more
-
Duarte, California
- +39 more
Oct 31, 2022
Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)
Not yet recruiting
- Lupus Nephritis
- Type 1 Diabetes Mellitus
- autologous adoptive T regulatory cell transfer.
-
Cairo, EgyptAin shams university, faculty of medicine
Sep 30, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (IMU-838 tablets, Placebo matching IMU-838 tablets)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- IMU-838 tablets
- Placebo matching IMU-838 tablets
-
Altamonte Springs, Florida
- +28 more
Jul 29, 2022
Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)
Completed
- Neurodermatitis
- Dupilumab SAR231893
- +4 more
-
Fort Smith, Arkansas
- +56 more
Dec 2, 2021
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Asthma Trial in Worldwide (Dupilumab SAR231893)
Recruiting
- Asthma
- Dupilumab SAR231893
-
Ciudad de Buenos Aires, Buenos Aires, Argentina
- +45 more
Jan 16, 2023
End Stage Renal Disease Trial in Chicago (Expanded Tregs)
Completed
- End Stage Renal Disease
- Expanded Tregs
-
Chicago, IllinoisNorthwestern University Comprehensive Transplant Center
Oct 4, 2019
Lupus Erythematosus, Systemic Trial in Worldwide (VIB7734, Placebo)
Active, not recruiting
- Lupus Erythematosus, Systemic
- VIB7734
- Placebo
-
La Jolla, California
- +88 more
Jan 10, 2023
Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)
Completed
- Leukemia, Myeloid, Acute
- Placebo
- +2 more
-
Los Angeles, California
- +121 more
Oct 25, 2021
Covid19 Trial in Worldwide (Novaferon, Placebo)
Recruiting
- Covid19
- Novaferon
- Placebo
-
Bahia Blanca, Argentina
- +87 more
Jun 1, 2022
COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Itepekimab SAR440340
- Placebo
-
Palm Springs, California
- +231 more
Dec 19, 2022
COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)
Active, not recruiting
- Chronic Obstructive Pulmonary Disease
- Dupilumab SAR231893
- +4 more
-
Andalusia, Alabama
- +286 more
May 11, 2022
Drug Concentration to Predict Recapture of Response in Crohn's
Completed
- Crohn's Disease
-
Calgary, Alberta, Canada
- +23 more
Mar 5, 2021